Works matching IS 20406207 AND DT 2018 AND VI 9 AND IP 11
Results: 1
Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 11, p. 335, doi. 10.1177/2040620718802606
- By:
- Publication type:
- Article